4//SEC Filing
Poll Claire 4
Accession 0001104659-23-010732
CIK 0001657312other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:15 PM ET
Size
17.8 KB
Accession
0001104659-23-010732
Insider Transaction Report
Form 4
Poll Claire
General Counsel
Transactions
- Exercise/Conversion
Ordinary Shares
2023-01-20+178,800→ 2,211,439 total - Gift
Ordinary Shares
2023-02-01+152,000→ 926,256 total(indirect: By Trust) - Gift
Ordinary Shares
2023-02-01−152,000→ 2,059,439 total - Sale
Ordinary Shares
2023-02-01$2.59/sh−152,000$394,273→ 774,256 total(indirect: By Trust) - Exercise/Conversion
Restricted Share Units
2023-01-20−86,272→ 0 totalExp: 2027-04-26→ Ordinary Shares (86,272 underlying) - Exercise/Conversion
Restricted Share Units
2023-01-20−34,248→ 0 totalExp: 2028-03-08→ Ordinary Shares (34,248 underlying) - Exercise/Conversion
Restricted Share Units
2023-01-20−58,280→ 8,328 totalExp: 2029-03-29→ Ordinary Shares (58,280 underlying)
Footnotes (6)
- [F1]Reported securities are represented by American Depositary Shares ("ADSs") (unless otherwise indicated), each of which represents eight (8) Ordinary Shares of the Issuer.
- [F2]Consists of (i) 1,820,000 Ordinary Shares underlying Restricted Share Units (each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer) (which may be represented by 227,500 ADSs); (ii) 239,432 Ordinary Shares underlying 29,929 ADSs; and (iii) 7 Ordinary Shares.
- [F3]Held by a family trust of which (a) the Reporting Person and spouse are trustees and (b) the Reporting Person and members of her immediate family are the sole beneficiaries of the trust.
- [F4]The sales reported in the Form 4 were effected solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units.
- [F5]The price reported represents the weighted average sale price of the ADSs divided by eight (8). These shares were sold in multiple transactions at prices ranging from $2.575 to $2.6138, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F6]Each Restricted Share Unit represents a contingent right to receive one (1) Ordinary Share of the Issuer (which may be represented by ADSs, each of which represents eight (8) Ordinary Shares of the Issuer) subject to certain time- and performance-based vesting criteria.
Documents
Issuer
Verona Pharma plc
CIK 0001657312
Entity typeother
Related Parties
1- filerCIK 0001836820
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 6:15 PM ET
- Size
- 17.8 KB